Alzinova participated in BIO-Europe 24-26 October 2022

Alzinova’s CEO Kristina Torfgård and CSO Anders Sandberg participated in one of the major biotech conferences in Europe, BIO-Europe, which is a forum for partner meetings, where the Company presented the vaccine candidate ALZ-101 and the antibody ALZ-201 to potential partners.